
Zepbound
TopicHeard in 3 episodes across 3 shows since Jun 2026
Zepbound is a brand name for tirzepatide, an anti-obesity medication used for chronic weight management and the treatment of obstructive sleep apnea in adults. It functions as a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Developed by Eli Lilly and Company, the drug is administered via weekly subcutaneous injections.
Episodes
3
across 3 shows
First heard
Jun 2026
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
1
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 1 |
| Jul 2026 | 1 |
| Aug 2026 | 0 |
| Sep 2026 | 1 |
| Oct 2026 | 0 |
Episodes
3 episodes featuring Zepbound, newest first
- Sep 3, 2026
Andrew Huberman reveals daily protocols to optimize brain and body performanceThe Diary Of A CEO with Steven BartlettSep 3, 2026 - Jul 1, 2026
Brian Noe makes the case against Team USAThe Ben Maller ShowJul 1, 2026 - Jun 23, 2026
Taylor Sheridan details ranching logistics and the brutal realities of the frontierThe Joe Rogan Experience: Protect Our ParksJun 23, 2026